report cover1

Biopharmaceutical CMO and CRO Market - Global Industry, Analysis, Size, Share, Growth, Trends, and Forecasts 2023-2030

Contract Manufacturing Organization (CMO), more recently referred to as a contract development and manufacturing organization (CDMO) to avoid the acronym confusion of Chief medical officer or Clinical monitoring organizations in the pharma industry, is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows the major companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead. CDMOs are contract manufacturers, yet they provide development as a standard part of their services. Their customers are not only expecting competitive pricing but also regulatory compliance, flexibility on the production capability, and on-time delivery.

 The pharmaceutical market uses outsourcing services from providers in the form of contract research manufacturing organizations (CROs) who work on very early-stage drug development on a microscopic scale providing medicinal chemistry services. These are often called CDROs as they provide some small scale-up and later stages of drug development often preparing material ranging from hundreds of grams to multi-kilo amounts. As the drug moves through the various clinical stages, the volume tends to grow as well. Commercial scale amounts could range from metric tons. The concept of a comprehensive single-source provider from drug development through commercial manufacture of drug substances and drug products has been tried to varying success. The best-positioned service providers focus on a specific technology or dosage form and promote end-to-end continuity and efficiency for their outsourcing clients.

Global Biopharmaceutical CMO and CRO Market – Competitive Landscape

On December 7, 2023, AbbVie acquired Cerevel. On October 15, 2023, Syngene International invested about USD 100 million annually in research and biologics. On August 26, 2021, Samsung Biologics eyes up to USD 430 million in maiden bond issue. On October 28, 2020, Syneos Health to acquired Synteract a top CRO provider to emerging Biopharma. On August 5, 2020, Catalyst Clinical Research announced a merger with Ce3 Inc. to form a market-leading next-generation oncology CRO.

Some of the Key Players in the Global Biopharmaceutical CMO and CRO Market Include –

  • Lonza
  • Rentschler Biotechnologies GmbH
  • Boehringer Ingelheim GmbH
  • JRS Pharma
  • Inno Biologics Sdn Bhd
  • ProBioGen
  • Samsung Biologics

Global Biopharmaceutical CMO and CRO Market – Growth Drivers

Growing global investments in biopharmaceutical research and development serve as a primary growth driver, fostering demand for CMO and CRO services to support drug discovery and development processes. The expanding market for biologics and biosimilars fuels the demand for specialized manufacturing and research services, providing significant growth opportunities for CMOs engaged in biopharmaceutical production. Biopharmaceutical companies outsource to CMOs and CROs for efficiency gains and cost-effectiveness, allowing them to leverage external expertise, infrastructure, and flexibility in resource management. Advances in bioprocessing technologies enhance the efficiency of biopharmaceutical manufacturing, driving demand for CMOs equipped with state-of-the-art facilities and expertise in implementing innovative production methods. Collaboration partnerships between biopharmaceutical companies and service providers create growth opportunities, enabling shared resources, expertise, and risk in the dynamic landscape of drug development. The rising complexity of clinical trials especially in areas like gene and cell therapies, boosts the demand for specialized CRO services, driving growth in the factor. The growing emphasis on precision medicine and targeted therapies necessitates specialized expertise, positioning CROs as key contributors in conducting focused clinical trials and research activities.

Global Biopharmaceutical CMO and CRO Market – Restraints

The biopharmaceutical CMO and CRO market faces challenges associated with stringent and evolving regulatory requirements, which can increase operational complexities and compliance costs. Intellectual property issues pose a restraint, as collaboration with CMOs and CROs involves sharing proprietary information, leading to concern about data protection and potential disputes over ownership rights. Setting up and maintaining state-of-the-art biopharmaceutical manufacturing and research facilities requires significant initial capital investment, which can be a restraint for both existing and new entrants in the CMO and CRO market. CMOs are often highly dependent on the pipeline of their client biopharmaceutical companies. Fluctuations or delays in client projects can impact the revenue streams and overall sustainability of CMOs. The industry is susceptible to global supply chain disruptions, as seen with events like the COVID-19 pandemic, affecting the timely delivery of material and impacting the efficiency of CMO and CRO operations. CROs face the risk of clinical trial failures, which can occur due to factors beyond their control, such as unforeseen safety issues or lack of efficiency, leading to financial setbacks and damage to reputation. Intense competition among CMOs and CROs can result in pricing pressures impacting profit margins. Maintaining competitive pricing while delivering high-quality services is a constant challenge in the market. The industry faces challenges in attracting and retaining skilled professionals, leading to talent shortages and turnover. This can impact the consistency and quality of services provided by CMOs and CROs.

Global Biopharmaceutical CMO and CRO Market – Opportunities

The increased global investments in biopharmaceutical research and development present substantial opportunities for CMOs and CROs to offer specialized services, driving innovation and drug development. Opportunities arise with the increasing adoption of advanced technologies, such as artificial intelligence, data analytics, and automation, enhancing the efficiency and productivity of CMO and CRO services. Biopharmaceutical companies increasingly outsource early-stage development activities to CROs, providing an opportunity for these service providers to engage in the critical phases of drug discovery and development.

Global Biopharmaceutical CMO and CRO Market – Geographical Insight

The global biopharmaceutical CMO and CRO market is segmented into regions such as North America, Latin America, Europe, Asia-Pacific, the Middle East & Africa. North America is the largest market for biopharmaceutical CMOs and CROs due to key players and a robust infrastructure supporting biopharmaceutical development. Europe is witnessing a growing presence in the biopharmaceutical outsourcing market with increased investments in research and development activities. The Asia-Pacific region is emerging as a significant hub for biopharmaceutical outsourcing, fueled by a combination of skilled workforce, cost advantages, and advancing regulatory framework.

Global Biopharmaceutical CMO and CRO Market – Key Development

  • On June 21, 2023, Saudi Arabia launched Lifera, a new CDMO.
  • On April 26, 2023, AmerisourceBergen unveils a hub to aid cell and gene therapy data exchange.
  • On February 23, 2023Lunaphore and CRO Sirona Dx collaborate to expand COMET™ offerings to US-based biotech.
Complete the form below and we'll get back to you shortly
Table of Content
Complete the form below and we'll get back to you shortly

Research Methodology: Aspects

Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.

The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.

Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.

Key phases involved in in our research process are mentioned below:


Understanding Clients’ Objectives:

Extensive Discussions and Consultations:

  • We initiate in-depth discussions and consultations with our clients to gain a comprehensive understanding of their objectives. This involves actively listening to their needs, concerns, and aspirations regarding the research project.
  • Through these interactions, we aim to uncover the underlying motivations driving their research requirements and the specific outcomes they hope to achieve.

Industry and Market Segment Analysis:

  • We invest time and effort in comprehensively understanding our clients’ industry and market segment. This involves conducting thorough research into market trends, competitive dynamics, regulatory frameworks, and emerging opportunities or threats.
  • By acquiring a deep understanding of the broader industry landscape, we can provide context-rich insights that resonate with our clients’ strategic objectives.

Target Audience Understanding:

  • We analyze our clients’ target audience demographics, behaviors, preferences, and needs to align our research efforts with their consumer-centric objectives. This entails segmenting the audience based on various criteria such as age, gender, income level, geographic location, and psychographic factors.
  • By understanding the nuances of the target audience, we can tailor our research methodologies to gather relevant data that illuminates consumer perceptions, attitudes, and purchase intent.


Identifying Challenges and Opportunities:

  • We proactively identify the challenges and opportunities facing our clients within their respective industries. This involves conducting SWOT (Strengths, Weaknesses, Opportunities, Threats) analyses and competitive benchmarking exercises.
  • By identifying potential obstacles and growth drivers, we can provide strategic recommendations that help our clients navigate complexities and capitalize on emerging opportunities effectively.

Grasping Specific Goals:

  • We delve into the intricacies of our clients’ objectives to gain clarity on the specific goals they aim to accomplish through the research. This entails understanding their desired outcomes, such as market expansion, product development, or competitive analysis.
  • By gaining a nuanced understanding of our clients’ goals, we can tailor our research approach to address their unique challenges and opportunities effectively.

Data Collection:


Primary Research Process:

  • Surveys: We design and administer surveys tailored to capture specific information relevant to our clients’ objectives. This may involve employing various survey methodologies, such as online, telephone, or face-to-face interviews, to reach target audiences effectively.
  • Interviews: We conduct structured or semi-structured interviews with key stakeholders, industry experts, or target consumers to gather in-depth insights and perspectives on relevant topics. These interviews allow us to probe deeper into specific issues and uncover valuable qualitative data.
  • Focus Groups: We organize focus group discussions with carefully selected participants to facilitate interactive discussions and gather collective opinions, attitudes, and preferences. This qualitative research method provides rich contextual insights into consumer behaviors and perceptions.
  • Observations: We conduct observational research by directly observing consumer behaviors, interactions, and experiences in real-world settings. This method enables us to gather objective data on consumer actions and reactions without relying on self-reported information.

Secondary Research Process:

  • Literature Review: We conduct comprehensive literature reviews to identify existing studies, academic articles, and industry reports relevant to the research topic. This helps us gain insights into previous research findings, theoretical frameworks, and best practices.
  • Industry Reports: We analyze industry reports published by reputable trade associations (whitepapers, research studies, etc.), and government agencies (U.S. Census Bureau, Bureau of Labor Statistics, and Securities and Exchange Commission etc.) to obtain macro-level insights into market trends, competitive landscapes, and industry dynamics.
  • Government Publications: We review government publications, such as economic reports, regulatory documents, and statistical databases, to gather relevant data on demographics, market size, consumer spending patterns, and regulatory frameworks.
  • Online Databases: We leverage online databases, such as industry portals, and academic repositories (PubMed Central (PMC), ScienceDirect, SSRN (Social Science Research Network), Directory of Open Access Journals (DOAJ), NCBI, etc.), to access a wide range of secondary data sources, including market statistics, financial data, and industry analyses.



Data Analysis:

The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.


Transformation of Raw Data:

  • Upon collecting the necessary data, we transition into the data analysis phase, where raw data is processed and transformed into actionable insights. This involves organizing, cleaning, and structuring the data to prepare it for analysis.

Utilization of Analytical Methods:

  • Depending on the research objectives, we employ a diverse range of analytical methods to extract meaningful insights from the data. These methods include statistical analysis, trend analysis, regression analysis, and qualitative coding.

Statistical Analysis:

  • Statistical tools are instrumental in uncovering patterns, correlations, and trends within the data. By applying statistical techniques such as descriptive statistics, hypothesis testing, and multivariate analysis, we can discern relationships and derive valuable insights.

Qualitative Analysis Techniques:

  • In addition to quantitative analysis, we leverage qualitative analysis techniques to gain deeper insights from qualitative data sources such as interviews or open-ended survey responses. One such technique is thematic coding, which involves systematically categorizing and interpreting themes or patterns within qualitative data.

Integrity and Validity Maintenance:

  • Throughout the analysis process, we maintain a steadfast commitment to upholding the integrity and validity of our findings. This entails rigorous adherence to established methodologies, transparency in data handling, and thorough validation of analytical outcomes.

Data Validation:

The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.


Importance of Data Validation:

  • Data validation is the final phase of the research methodology, crucial for ensuring the reliability and credibility of the findings. It involves a systematic process of reviewing and verifying the collected data to detect any inconsistencies, errors, or biases.

Scrutiny of Collected Data:

  • The validation process begins with a thorough scrutiny of the collected data to identify any discrepancies or anomalies. This entails comparing data points, checking for outliers, and verifying the accuracy of data entries against the original sources.

Validation Techniques:

  • Various validation techniques are employed to ensure the accuracy and integrity of the data. These include cross-referencing data from multiple sources to corroborate findings, conducting validity checks on survey instruments to assess the reliability of responses, and seeking feedback from independent experts or peer reviewers to validate the interpretation of results.

Internal Quality Assurance Protocols:

  • In addition to external validation measures, internal quality assurance protocols are implemented to further validate the accuracy of the analysis. This may involve conducting internal audits, peer reviews, or data validation checks to ensure that the research process adheres to established standards and guidelines.
- Get Started -

Get insights that lead to new growth opportunities

Need a Custom Report?

We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Business Development

small c popup.png
Buy Now
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
Ask an Expert